Injectable chlorpheniramine/hyoscyamine recalled for sterility assurance failure
Pharmacy Innovations has recalled Chlorpheniramine/Hyoscyamine injectable medication nationwide due to insanitary facility conditions identified during FDA inspection that compromise product sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a high-risk product category (sterile injectables) with documented sterility assurance failure from facility conditions. No reported illnesses or injuries appear in the source material, placing this at Score 3 (High) per the rubric criterion for risk-of-harm products without documented injury.
Plain-English summary
Pharmacy Innovations, located at 2936 W 17th St., Erie, Pennsylvania, has recalled Chlorpheniramine/Hyoscyamine 10 mg/0.25 mg per 1 mL injectable medication nationwide. An FDA inspection revealed insanitary conditions at the manufacturing facility that compromise the sterility assurance for this injectable product.
Chloropheniramine/Hyoscyamine is an Rx-only antihistamine and anticholinergic medication administered by injection. The recalled product code is t20221026@41 and was distributed nationwide. Injectable medications require strict sterility to ensure safety.
Healthcare providers who have this product should verify their inventory and quarantine any affected units. Patients who have received this medication should contact their healthcare provider regarding potential exposure from this recall.
The recalled product
- Product
- Chlorpheniramine/Hyoscyamine (1ML) 10MG/0.25MG/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
- Manufacturer
- Pharmacy Innovations
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221026@41
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 59 recalled by Pharmacy Innovations under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 59 products in this recall →Related recalls
Same manufacturer · Pharmacy Innovations
See all →- HighEdetate Disodium Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighInjectable Hydroxocobalamin Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighFDA Recalls Acetylcysteine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighMethylcobalamin Injectable Recall Due to Facility Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighInjectable vitamin B-complex products recalled for lack of sterility assurance
FDA (Drugs) · 2023-02-01
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15